The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,254.00
Bid: 12,254.00
Ask: 12,256.00
Change: 8.00 (0.07%)
Spread: 2.00 (0.016%)
Open: 12,240.00
High: 12,306.00
Low: 12,228.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Caution prevails in world markets ahead of Fed

Wed, 17th Mar 2021 09:40

* Investors watching for signs of faster policy
normalisation

* Fed statement due at 1800 GMT

* European shares open weaken

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh

By Dhara Ranasinghe

LONDON, March 17 (Reuters) - Caution descended on markets on
Wednesday with world stocks holding below recent record highs as
investors waited to see whether the U.S. Federal Reserve would
signal a faster path toward policy normalisation than previously
expected.

The U.S. central bank ends a closely anticipated two-day
meeting later in the day, after a sharp rise in U.S. Treasury
yields this year on expectations for stronger growth and
inflation.

The Fed is expected to forecast that the U.S. economy will
grow in 2021 at the fastest rate in decades. But investors who
expect rosier projections to translate to any change in monetary
policy will probably be disappointed.

"This is one of the most important Fed meetings we've had
for some time and the impact will be felt across asset classes,"
said Seema Shah, chief strategist at Principal Global Investors.

"Markets are hoping for reassurance from the Fed that rising
bond yields are not something to worry about, and that takes a
bit of steam out of the bond market."

Before the Fed statement at 1800 GMT, calm prevailed across
world markets.

MSCI's world equity index was down 0.1%, but
keeping last month's record highs within sight.

European shares were a touch softer ,
while in Asia, an index of regional equities excluding Japan
pulled back 0.4%. Japan's Nikkei 225
closed flat.

There was some good news for AstraZeneca as
Australia's pharmaceutical regulator said the rollout of the
company's COVID-19 vaccine would continue, even though many
European nations have paused vaccinations to investigate
reported side-effects.

U.S. stock futures pointed to a flat open on Wall
Street, after the S&P 500 lost 0.16% on Tuesday.

DOVISH?

Benchmark 10-year Treasury yields were a touch
higher at 1.63%, holding near 13-month highs reached on Friday.
They have risen 72 basis points so far this year. That compares
with a 24 bps increase in German peers and a 7 bps
rise in Japanese borrowing costs.

Inflation expectations have also ticked higher with the
break-even rate on 10-year Treasury Inflation-Protected
Securities (TIPS) on Tuesday rising above 2.3% for
the first time since July 2014. The break-even rate for 30-year
TIPS hit 2.24%, the highest since September 2014.

"We expect (Fed Chair Jerome) Powell to note the FOMC has
the tools to intervene if the bond market becomes disorderly or
constrains the economic recovery," analysts at Commonwealth Bank
of Australia wrote.

"But we expect Powell to push back against talk of policy
tightening because of the large amount of labour market slack
... U.S. bond yields and the U.S. dollar could jump if the
FOMC’s post-meeting statement and Powell’s statement are not
deemed dovish enough."

An index tracking the dollar against six major peers
was around 91.92. The euro was weaker on the day at $1.1892
. The dollar was up about 0.1% at 109.13 yen.

Currency market caution may extend all week, with the Bank
of England meeting on Thursday and the Bank of Japan wrapping up
a policy review on Friday, in which it may phase out a numerical
target for its asset buying.

Elsewhere, oil prices slipped for a fourth day as concern
about weaker demand in Europe outweighed an industry report that
showed U.S. crude stockpiles unexpectedly fell last week.

Brent crude futures fell 27 cents to $68.12 a barrel
and U.S. crude futures slipped 14 cents to $64.65.

For Reuters Live Markets blog on European and UK stock
markets, please click on:

(Reporting by Dhara Ranasinghe; Additional reporting by Kevin
Buckland in Tokyo; editing by Larry King)

More News
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.